A case of immune-related adverse effect diffuse gastritis induced by nivolumab-Reference-Cited by-同舟云学术

A case of immune-related adverse effect diffuse gastritis induced by nivolumab

Published:2021-06-25 Issue:1 Volume:98 Page:91-92
ISSN:1348-9844
Container-title:Progress of Digestive Endoscopy
language:en
Short-container-title:Prog. dig. Endosc

Author:

Sakai Miho¹,Haga Yuki¹,Kambe Michiyo²,Nishimura Koji¹,Shingyouchi Ayako¹,Miyamura Tatsuo¹,Ito Kenji¹,Abe Asami¹,Kaneda Satoru¹,Tada Minoru¹,Saito Masaaki¹,Sugiura Nobuyuki¹

Affiliation:

1. Department of Gastroenterology, National Hospital Organization Chiba Medical Center

2. Department of Pathology, National Hospital Organization Chiba Medical Center

Publisher

Japan Gastrointestinal Endoscopy Society

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/pde/98/1/98_91/_pdf

Reference8 articles.

1. 1) 岩井佳子: 免疫チェックポイントの機能とがん治療への応用-ニボルマブの発明-. 日内会誌 108: 1766-1771, 2019

2. 2) Brahmer JR, Lacchetti C, Schneider BJ, et al: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36: 1714-1768, 2018

3. 3) Nishimura Y, Yasuda M, Ocho K, et al: Severe Gastritis after Administration of Nivolumab and Ipilimumab. Case Rep Oncol 11: 549-556, 2018

4. 4) Boike J, Dejulio T: Severe Esophagitis and Gastritis from Nivolumab Therapy. ACG Case Rep J 4: e57, 2017

5. 5) Vindum HH, Agnholt JS, Nielsen AWM, et al: Severe steroid refractory gastritis induced by Nivolumab: A case report. World J Gastroenterol 26: 1971-1978, 2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of severe immune checkpoint inhibitor-related gastritis requiring differential diagnosis from scirrhous carcinoma;Progress of Digestive Endoscopy;2023-12-22